Topics

Latest "FUJIFILM Irvine Scientific, Inc." News Stories

15:57 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "FUJIFILM Irvine Scientific, Inc." found in our extensive news archives from over 250 global news sources.

More Information about FUJIFILM Irvine Scientific, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about FUJIFILM Irvine Scientific, Inc. for you to read. Along with our medical data and news we also list FUJIFILM Irvine Scientific, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of FUJIFILM Irvine Scientific, Inc. Companies for you to search.

Showing "FUJIFILM Irvine Scientific" News Articles 1–25 of 7,400+

Thursday 20th February 2020

Global Cannabis Testing Market 2018-2022 | Evolving Opportunities with Agilent Technologies and Merck Group | Technavio

Technavio has been monitoring the global cannabis testing market since 2017 and the market is expected to grow by USD 793 million during 2018-2022, progressing at a CAGR of more than 12% during the forecast period. Request free sample pages This press release features multimedia. View the


Ongoing Studies May Clarify Role of ADCs in Gastric Cancer and CRC

Although fam-trastuzumab deruxtecan-nxki has efficacy in HER2-positive breast cancer, data to support the agent’s use in other disease settings, such as HER2-expressing gastric and colorectal cancers, are limited and further investigation is necessary, according to a panel of experts in HER2-positive gastrointestinal malignancies who convened recently at the OncLive® Scientific Interchan...

Clark Construction Achieves Fitwel Certification in Offices Nationwide

Clark Construction Group today announced that it has achieved Fitwel certification in six of its corporate offices across the nation. With this milestone, Clark has demonstrated that it is committed to providing best-in-class and healthy workspaces for its employees. Fitwel, an evidence-based healthy building certification, aims to support healthier workplace environments and improve occupant h...


OncLive® Presents Live Coverage of the 2020 Transplantation & Cellular Therapy Meetings

OncLive®, the nation’s leading digital resource providing oncology professionals with current, insightful information to help them deliver the best patient care, presents OncLive® News Network On-Location. Host Gina Columbus, Managing Editor of OncLive®, will provide live coverage of the 2020 Transplantation & Cellular Therapy (TCT) Meetings in Orlando, Florida, on Saturday, Feb. 22. ...

LabRoots Announces Highly Anticipated 3rd Annual Drug Discovery & Development Virtual Event commencing on February 26th, 2020

Drug Discovery & Development presents a dynamic, global forum with a stellar agenda for attendees to learn the latest strategies and innovative technologies for drug discovery methodologies YORBA LINDA, Calif. (PRWEB) February 20, 2020 LabRoots, the leading scientific social networking website offering premier, interactive virtual events and webinars, will be focused on covering “State-of-...

We know the best science doesn’t happen in isolation which is why we work collaboratively to fuel scientific discovery. Siobhan McMahon from @benevolent_ai discusses the ingredients needed for a successful collaboration. http://bit.ly/2P0jOUg pic.twi

We know the best science doesn’t happen in isolation which is why we work collaboratively to fuel scientific discovery. Siobhan McMahon from @benevolent_ai discusses the ingredients needed for a successful collaboration. http://bit.ly/2P0jOUg  pic.twitter.com/lskPMX8psT

Verana Health Appoints Veteran Cardiologist and Clinical Researcher, Dr. Matthew Roe, as Chief Medical Officer

Verana Health today announced the appointment of Matthew Roe, MD, MHS, as Chief Medical Officer. A cardiologist and clinical researcher, Dr. Roe joins Verana Health after spending over two decades at the Duke University School of Medicine and the

Eureka Therapeutics to Present at 6th Annual Immuno-Oncology 360° Conference

Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced that President and CEO Dr. Cheng Liu will be presenting at the 6th Annual Immuno-Oncology 360° Conference (IO360°) in New York on February 27, 2020. Dr. Liu will be presenting the use of Eureka’s novel antibody-TCR receptor (ARTEMIS® T cell) that has be...

Stemina’s Human Induced Pluripotent Stem Cell Test Predicts Drug Cardiovascular Toxicity

Study reports on the first human cellular and metabolomics-based test for the evaluation of drugs for cardiotoxic effects Stemina Biomarker Discovery, Inc., today announced study results showing the high performance of the company’s Cardio quickPredict test in identifying cardiotoxic effects for a large number of well-characterized drugs. These results suggest the drug screening test could pro...

HeartVista Announces Formation of Medical and Scientific Advisory Board with Leaders from Stanford University and the University of Wisconsin

HeartVista, a pioneer in AI-assisted MRI solutions, announced the formation of its Medical and Scientific Advisory Board, including notable thought leaders from Stanford University and the University of Wisconsin. “The past year was an inflection point for HeartVista, which was full of significant milestones as we received FDA 510(k) clearance for our AI-assisted One Click™ Cardiac Package,...

Alnylam to Webcast Presentation at 9th Annual SVB Leerink Global Healthcare Conference

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 9th Annual SVB Leerink Global Healthcare Conference on Thursday, February 27, 2020 at 9:30 am ET at the Lotte New York Palace Hotel in New York City. A live audio webcast of the

Bruker Announces Quarterly Dividend

Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on March 20, 2020 to stockholders of record as of March 9, 2020. About Bruker Corporation (Nasdaq: BRKR) Bruker is enabling scientists to make breakthrough discoveries and dev...

Dyve Biosciences Announces First Patient Enrolled in TARGETS Study for Treatment of Acute Gout

Dyve’s Phase 2 trial is designed to enroll 300 subjects across 20 trial centers in the U.S. Dyve Biosciences, a research and drug development company using proprietary science to create novel therapeutics, today announced it has enrolled its first patient in TARGETS, a Phase 2 clinical study of DYV-700, the company’s topically administered therapeutic being developed as a treatment for acute...

Infinitus releases 2019 Corporate Social Responsibility Report promoting a healthy lifestyle

GUANGZHOU, China, Feb. 20, 2020 /PRNewswire/ -- The general public has come to see the taking of social responsibility as a basic requirement of all companies. On February 20, Infinitus (China) Company Ltd released its 2019 Corporate Social Responsibility Report on its online platform. Given the challenges posed by 2019-nCoV, Infinitus hopes, through the report, to give stakeholders more conf...

Sai Strengthens Leadership Team

Accomplished scientific leader and GSK veteran, Dean Edney joins the CDMO

Efficient Assistance, YITU AI Aids Epidemic Prevention and Control of COVID-19 Outbreak

Since the outbreak of COVID-19, Yitu Healthcare responded quickly and launched an operation of multiple departments. The main R & D team sacrificed their vacations, worked around the clock for several consecutive days and finally completed the development of the Intelligent Evaluation System of Chest CT for COVID-19 in a very short period of time. The system was launched during the Chinese Sp...

Global 3D Cell Culture Market Data Survey Report 20152025 [Published by HeyReport] Prices from USD $1275

SummaryA 3D cell culture is an artificiallycreated environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments e.g. a petri dish, a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. These threedimensional cultures are usually grown in bioreactors, small capsules in ...

Wednesday 19th February 2020

New agreement to accelerate nutrition testing worldwide

Trajan Nutrition has signed a memorandum of understanding (MOU) with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by Professors Maria Makrides and Robert Gibson. Trajan Scientific and Medical established Trajan Nutrition in 2017 as a joint venture with Prof Makrides and Prof Gibson. Under t...

Homology Medicines to Participate in Upcoming Investor and Scientific Conferences

BEDFORD, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today participation and presentations at the following investor and scientific conferences: BTIG Targeted Therapeutics Conference at The St. Regis New York Panel presentation, “Gene Therapy: How Do You Build More Than a One-Stop-Shop to Derive Value?”: ...

New results on the function of the tumor suppressor HERC protein

(University of Barcelona) The RAF protein could be a therapeutical target to treat the tumor growth in regulated pathways by the p38 protein, according to a new study published in the journal Scientific Reports by a team of experts of the Faculty of Medicine and Health Sciences of the University of Barcelona and the Bellvitge Institute for Biomedical Research (IDIBELL).

Turning Point Therapeutics Names Siegfried Reich as Executive Vice President and Chief Scientific Officer

SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the appointment of Siegfried Reich, Ph.D. as executive vice president and chief scientific officer effective March 2. Dr. Reich has over 25 years of pharmaceutical and biotech ...

20172025 World Laboratory Water Purifier Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

SummaryLaboratory water purifier is used to remove impurities, salt ions, bacteria and viruses from water in the laboratory. The processes include capacitive deionization, reverse osmosis, carbon filtering, microfiltration, ultrafiltration, ultraviolet oxidation, or electro deionization.Purified water is a common requirement within all laboratories, particularly research, infection control and pat...

QIAGEN’s QuantiFERON®-TB Gold Plus to be Adopted for Latent TB Testing in Nigeria

Nigerian Ministry of Health publishes guidelines highlighting QIAGEN’s gold standard blood test for latent TB as part of their “test and treat” strategy to fight the disease Largest economy in Africa is the first country to recommend only QuantiFERON®-TB Gold Plus as standard IGRA High-risk population will now be screened for latent tuberculosis QIAGEN (NYSE: QGEN; Frankfurt Prime ...

Diagnosis and Treatment of Fulminant Myocarditis

Highlights of a scientific statement from the American Heart Association

Even If Vital Strategies Won’t Talk with Us, Philip Morris International Wants to Talk About a Smoke-Free Future

This morning, Dr. Moira Gilchrist, a leading scientist with Philip Morris International Inc. (PMI) (NYSE: PM), was denied entry to an e-cigarette forum hosted by the special-interest group, Vital Strategies. We have to ask why. The world is home to more than 1 billion people who smoke today. Can we at least talk about their right to better alternatives than continuing to smoke?


Quick Search

News Quicklinks